BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 29086922)

  • 1. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
    Duivenvoorden HM; Rautela J; Edgington-Mitchell LE; Spurling A; Greening DW; Nowell CJ; Molloy TJ; Robbins E; Brockwell NK; Lee CS; Chen M; Holliday A; Selinger CI; Hu M; Britt KL; Stroud DA; Bogyo M; Möller A; Polyak K; Sloane BF; O'Toole SA; Parker BS
    J Pathol; 2017 Dec; 243(4):496-509. PubMed ID: 29086922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
    Lah TT; Nanni I; Trinkaus M; Metellus P; Dussert C; De Ridder L; Rajcević U; Blejec A; Martin PM
    J Neurosurg; 2010 May; 112(5):940-50. PubMed ID: 19747051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
    Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL
    Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma
    Lo PK; Zhang Y; Yao Y; Wolfson B; Yu J; Han SY; Duru N; Zhou Q
    J Biol Chem; 2017 Jul; 292(27):11466-11484. PubMed ID: 28512126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer.
    Rossetti S; Bshara W; Reiners JA; Corlazzoli F; Miller A; Sacchi N
    Cancer Lett; 2016 Oct; 380(2):375-383. PubMed ID: 27422542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
    Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
    J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse-INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancy.
    Hong Y; Limback D; Elsarraj HS; Harper H; Haines H; Hansford H; Ricci M; Kaufman C; Wedlock E; Xu M; Zhang J; May L; Cusick T; Inciardi M; Redick M; Gatewood J; Winblad O; Aripoli A; Huppe A; Balanoff C; Wagner JL; Amin AL; Larson KE; Ricci L; Tawfik O; Razek H; Meierotto RO; Madan R; Godwin AK; Thompson J; Hilsenbeck SG; Futreal A; Thompson A; Hwang ES; Fan F; Behbod F;
    J Pathol; 2022 Feb; 256(2):186-201. PubMed ID: 34714554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence.
    Allen MD; Thomas GJ; Clark S; Dawoud MM; Vallath S; Payne SJ; Gomm JJ; Dreger SA; Dickinson S; Edwards DR; Pennington CJ; Sestak I; Cuzick J; Marshall JF; Hart IR; Jones JL
    Clin Cancer Res; 2014 Jan; 20(2):344-57. PubMed ID: 24150233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TBX3 promotes progression of pre-invasive breast cancer cells by inducing EMT and directly up-regulating SLUG.
    Krstic M; Kolendowski B; Cecchini MJ; Postenka CO; Hassan HM; Andrews J; MacMillan CD; Williams KC; Leong HS; Brackstone M; Torchia J; Chambers AF; Tuck AB
    J Pathol; 2019 Jun; 248(2):191-203. PubMed ID: 30697731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
    Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P
    Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients.
    Levicar N; Kos J; Blejec A; Golouh R; Vrhovec I; Frkovic-Grazio S; Lah TT
    Cancer Detect Prev; 2002; 26(1):42-9. PubMed ID: 12088202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everolimus Inhibits the Progression of Ductal Carcinoma
    Chen G; Ding XF; Pressley K; Bouamar H; Wang B; Zheng G; Broome LE; Nazarullah A; Brenner AJ; Kaklamani V; Jatoi I; Sun LZ
    Clin Cancer Res; 2020 Mar; 26(6):1486-1496. PubMed ID: 31871301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary stem cells and breast cancer--role of Notch signalling.
    Farnie G; Clarke RB
    Stem Cell Rev; 2007 Jun; 3(2):169-75. PubMed ID: 17873349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
    Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE
    Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis.
    Zubeldia-Plazaola A; Recalde-Percaz L; Moragas N; Alcaraz M; Chen X; Mancino M; Fernández-Nogueira P; Prats de Puig M; Guzman F; Noguera-Castells A; López-Plana A; Enreig E; Carbó N; Almendro V; Gascón P; Bragado P; Fuster G
    Breast Cancer Res; 2018 Jul; 20(1):65. PubMed ID: 29973218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-content siRNA 3D co-cultures to identify myoepithelial cell-derived breast cancer suppressor proteins.
    Duivenvoorden HM; Brockwell NK; Nowell CJ; Simpson KJ; Parker BS
    Sci Data; 2021 May; 8(1):147. PubMed ID: 34050191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of an oligo-gene signature for the prognostic stratification of ductal carcinoma in situ (DCIS).
    Geradts J; Groth J; Wu Y; Jin G
    Breast Cancer Res Treat; 2016 Jun; 157(3):447-59. PubMed ID: 27250000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural EGFL like 2 expressed in myoepithelial cells and suppressed breast cancer cell migration.
    Nakamura R; Oyama T; Inokuchi M; Ishikawa S; Hirata M; Kawashima H; Ikeda H; Dobashi Y; Ooi A
    Pathol Int; 2021 May; 71(5):326-336. PubMed ID: 33657249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel myoepithelial/progenitor cell marker in the breast?
    Kolar Z; Ehrmann J; Turashvili G; Bouchal J; Mokry J
    Virchows Arch; 2007 May; 450(5):607-9. PubMed ID: 17429688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.